The Food and Drug Administration (FDA) has introduced a new regulatory framework aimed at facilitating the approval of personalized gene editing treatments. This initiative, termed the...
A significant concern has emerged regarding a multistate outbreak of botulism associated with infant formula produced by New York-based ByHeart. The Centers for Disease Control and...
A multistate outbreak of botulism has been associated with infant formula products manufactured by New York-based ByHeart. The outbreak may have originated from whole milk powder...
Stoke Therapeutics announced that its request for an expedited filing of a treatment for severe epilepsy has been delayed by the Food and Drug Administration (FDA)....
The death of Hannah Goetz on July 16, 2023, has ignited serious concerns regarding the efficacy of generic drugs approved by the Food and Drug Administration...
Multiple chocolate and cookie products are being recalled across several states due to the presence of undeclared allergens. The recalls, announced on December 23, 2023, by...
Concerns over the presence of pets in food establishments have prompted renewed calls for enforcement of existing regulations. In a letter published on December 13, Michael...
Cytokinetics has achieved a significant milestone with the approval of its first drug in the United States. On October 27, 2023, the U.S. Food and Drug...
Cytokinetics has achieved a significant milestone with the approval of its first U.S. drug, Myqorzo, by the Food and Drug Administration (FDA). This approval, granted on...
The future of the biopharmaceutical industry faces significant challenges, according to the former head of research and development at Pfizer. In a recent opinion piece, he...
